The results of the survey indicate that overall, more than two-thirds of respondents have used or would consider using marijuana or cannabinoid
compounds, including cannabidiol (CBD) and tetrahydrocannabinol, to manage pain.
(OTCQB: EMBI), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, announced today that Brian Murphy, MD, Chief Executive Officer of Emerald Bioscience will present at several upcoming investment and scientific events in September, including Rodman & Renshaw's 21st Annual Global Investment Conference, the 2nd Annual International Cannabinoid
Derived Pharmaceuticals Summit (ICDP), and Fall Investor Summit.
When shopping for CBD products, you'll run into three phrases that will define your cannabinoid
experience: broad spectrum CBD, full spectrum CBD, and CBD isolates.
Pyxus International has signed an agreement with Cornell University's College of Agriculture and Life Sciences to fund research designed to identify and address knowledge gaps surrounding hemp production through the evaluation of cannabidiol hemp cultivars and cannabinoid
Among more than 1,000 adults aged 18 and older, more than two-thirds have used or would consider using marijuana or cannabinoid
compounds, including cannabidiol (CBD) and tetrahydrocannabinol (THC).
Emeritus Professor Roger Pertwee has been celebrated with a lifetime achievement award for his cannabis and cannabinoid
Even though CBD oil is from the cannabis plant, it is not psychoactive and doesn't create a "high"--an effect caused rather by THC (9-tetrahydrocannabinol), another cannabinoid
World Canna Health, which promotes cannabinoid
education and business is bringing its exclusive Cannabinologer[TM] training to Texas.
therapy is being efficiently used for various neuropathic syndromes as well as epileptic conditions like Dravet and Lennox-Gastaut syndrome
[UKPRwire, Sun Jul 07 2019] The growing popularity of cannabis among the youth and legalization of recreational cannabis globally are the major factors responsible for driving the Cannabinoid
Therapy Market .
receptor type 1 (CB1) are mostly found in the brain, and also in the male and female reproductive systems.
The relatively recent discovery of the endogenous cannabinoid
system and the quickly evolving, yet still convoluted, legal status of cannabis in the United States has spurred excitement over expanded research opportunities.